Skip to main content

Eli Lilly Reports Temporary Shortage of Humalog and Insulin Lispro Injection

Medically reviewed by Carmen Pope, BPharm. Last updated on March 26, 2024.

By Physician’s Briefing Staff HealthDay Reporter

MONDAY, March 25, 2024 -- Eli Lilly & Co. announced on Friday a temporary shortage of two of its insulin products.

"The 10 mL vials of Humalog and Insulin Lispro Injection are or will be temporarily out of stock at wholesalers and some pharmacies through the beginning of April," Lilly said in a recent statement. The company added it is continuing to make the 10-mL vials and "will ship them as soon as we can." However, in the meantime, patients with diabetes may need to consult with their doctors "to discuss switching to the same insulin in a prefilled pen or other insulin treatment options."

Switching to another product may be more easily said than done, noted patient advocate Laura Marston. She has type 1 diabetes and uses Humalog. Marston told CNN that she uses the vials in her insulin pump. Her insurance only covers the vials through a prior authorization process that may be tough to get around. "If Lilly doesn't fix this fast, I actually don't know what I'm going to do," Marston said.

Lilly said it is offering customers without insurance a coupon program offering insulin for $35. "We recognize that any supply challenge may cause a disruption in people's treatment regimens, and we are moving with urgency to address it," its statement said. "Patients who need insulin immediately and cannot access their health care provider for an alternative treatment option should seek emergency care."

Lilly spokesman Tarsis Lopez told CNN that the "dynamic nature of insulin supply and demand, coupled with a brief delay in manufacturing, led to the temporary supply constraint."

CNN Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults

WEDNESDAY, May 22, 2024 -- For adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023, according to a research...

Men Face More Diabetes Complications Than Women

FRIDAY, May 17, 2024 -- Men with diabetes have a greater risk for complications than women, irrespective of diabetes duration, according to a study published online May 16 in...

AI-Informed Health App Aids Diabetes Outcomes

WEDNSDAY, May 15, 2024 -- Use of an artificial intelligence (AI)-informed health app aids diabetes outcomes and cuts atherosclerotic cardiovascular disease (ASCVD) risk, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.